Streetbeat News

Products Services

LUNR

Intuitive Machines Inc (NASDAQ:LUNR) shares are experiencing volatility due to updates on its Moon landing mission. The company's Nova-C class lunar lander, launched on SpaceX's Falcon 9 rocket, is en route to the Moon and performed a precise lunar orbit insertion. The mission, part of NASA's Commercial Lunar Payload Services, is on track for a landing. High trading volumes and stock halts were noted, with volatility attributed to low float and high short interest. Fourth quarter financial results are anticipated soon, with expectations of a loss and specific revenue figures.

Portfolio Pulse from Adam Eckert

February 21, 2024 | 4:45 pm

ZVSA

ZyVersa Therapeutics' shares surged as traders shared a company publication from Oct 25, 2023, highlighting its NLRP3 drug IC 100, aimed at treating inflammation linked to serious conditions like obesity-related heart disease.

Portfolio Pulse from Benzinga Newsdesk

February 21, 2024 | 4:43 pm

INTC

Intel launched Intel Foundry, aiming to be a leading systems foundry for the AI era, with a focus on sustainability. It announced an expanded process roadmap, including the Intel 14A process and specialized node evolutions. Microsoft plans to produce a chip design on Intel 18A process. Ecosystem partners like Synopsys, Cadence, Siemens, and Ansys are ready to support Intel Foundry customers. Intel aims for leadership in process technology by 2025 and has design wins across several process generations. The company also introduced collaborations for Arm-based SoCs and aims to be the most sustainable foundry.

Portfolio Pulse from Benzinga Newsdesk

February 21, 2024 | 4:33 pm

KZIA

Kazia Therapeutics shares experienced increased volatility and are trading lower after initially spiking, following the announcement of the early conclusion of the Phase 1 Paxalisib trial in solid tumors upon reaching the primary endpoint.

Portfolio Pulse from Benzinga Newsdesk

February 21, 2024 | 4:19 pm

DOGEUSD

GME

SHIBUSD

Benzinga's poll reveals GME Coin as the most popular meme coin among its social media followers, with Shiba Inu in second place. The interest in meme coins is rising, influenced by the cryptocurrency market's optimism and events like the approval of Bitcoin ETFs. GME Coin, inspired by GameStop but not affiliated, gained traction due to the 'Dumb Money' Netflix release and its narrative aligning with crypto traders' sentiments. Solana led 2023 returns among major cryptocurrencies, followed by Bitcoin, Ethereum, and Dogecoin.

Portfolio Pulse from Chris Katje

February 21, 2024 | 4:15 pm

CMND

SPRC

SciSparc Ltd. (NASDAQ:SPRC) and Clearmind Medicine Inc. (NASDAQ:CMND) have filed three patent applications for novel psychedelic compound combinations, aiming to enhance their market position and attract investments for mental health treatments. The patents involve combinations of LSD, psilocybin, DMT, and PEA, with the latter being the active ingredient in SciSparc's CannAmide. This collaboration seeks to protect their innovative therapies exclusively. Following the announcement, SPRC's shares rose by 2.74%, while CMND's shares fell by 7.79%.

Portfolio Pulse from Patricio Liddle

February 21, 2024 | 4:12 pm

JNJ

The FDA has approved Johnson & Johnson's (NYSE:JNJ) application for a reduced dosing frequency of Tecvayli in patients with relapsed or refractory multiple myeloma (RRMM) who have maintained a complete response for at least six months. This approval, based on the Phase 1/2 MajesTEC-1 study, allows for a dosing frequency of 1.5 mg/kg every two weeks. Tecvayli, a bispecific antibody targeting BCMA and CD3, was initially approved in October 2022 for RRMM patients after at least four prior lines of therapy. Over 3,600 patients in the U.S. have been prescribed Tecvayli since its approval.

Portfolio Pulse from Vandana Singh

February 21, 2024 | 4:04 pm

IDYA

IDEAYA Biosciences (NASDAQ:IDYA) has seen varied analyst opinions over the past quarter, with recent updates showing a shift towards more bullish stances. The average 12-month price target has increased to $46.5, up from $37.20, indicating a positive outlook on the company's future. Analysts from firms like RBC Capital and Goldman Sachs have raised their price targets, reflecting optimism about IDEAYA's market position and its oncology-focused precision medicine developments. Despite a significant revenue decline of -72.94% as of September 30, 2023, the company's strong net margin and ROE suggest effective cost control and equity capital utilization.

Portfolio Pulse from Benzinga Insights

February 21, 2024 | 4:01 pm

SOGP

Sound Group shares are trading higher following the announcement of launching new AI-powered applications for the international market.

Portfolio Pulse from Benzinga Newsdesk

February 21, 2024 | 3:59 pm

AAPL

NOK

NVDA

SSNLF

Nokia Corp (NYSE:NOK) and Nvidia Corp (NASDAQ:NVDA) have announced a partnership to develop AI-driven radio access network (RAN) solutions, aiming to transform telecommunications with advanced AI services. This collaboration will leverage Nvidia's Grace CPU Superchip and Nokia's Cloud RAN software and technology to enhance telco networks. Additionally, Nokia reported a 23% decline in Q4 2023 net sales but highlighted significant deals with Apple Inc (NASDAQ:AAPL), Samsung Electronics (OTC:SSNLF), and OPPO.

Portfolio Pulse from Anusuya Lahiri

February 21, 2024 | 3:57 pm